Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-19T12:14:06.613Z Has data issue: false hasContentIssue false

Focus on Women's Mental Health

Published online by Cambridge University Press:  01 February 2011

Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Guest Editors Note
Copyright
Copyright © Cambridge University Press 2012

Footnotes

Faculty Disclosures: Dr. Kornstein has been a consultant to Bristol-Myers Squibb, Dey Pharma, Eli Lilly, PGxhealth, Pfizer, Rexahn, and Takeda; has received research support from Boehringer-Ingelheim, Bristol-Myers Squibb, Eli Lilly, Forest Laboratories, the National Institute of Mental Health, Novartis, Otsuka, Pfizer, and Takeda; and has received book royalties from Guilford Press.Dr. Clayton has been a consultant to and/or on the advisory boards of AstraZeneca, Boehringer-Ingelheim, Bristol-Myers Squibb, Eli Lilly, New England Research Institutes, Pfizer, PGxHealth, sanofi-aventis and Takeda; has received grant support from BioSante, Boehringer-Ingelheim, Pfizer, and Repligen Corporation; and receives royalties from Ballantine Books/Random House; Guilford Publications; the Changes in Sexual Functioning Questionnaire; and Healthcare Technology Systems, Inc.

References

Faculty Disclosures: Dr. Kornstein has been a consultant to Bristol-Myers Squibb, Dey Pharma, Eli Lilly, PGxhealth, Pfizer, Rexahn, and Takeda; has received research support from Boehringer-Ingelheim, Bristol-Myers Squibb, Eli Lilly, Forest Laboratories, the National Institute of Mental Health, Novartis, Otsuka, Pfizer, and Takeda; and has received book royalties from Guilford Press.Dr. Clayton has been a consultant to and/or on the advisory boards of AstraZeneca, Boehringer-Ingelheim, Bristol-Myers Squibb, Eli Lilly, New England Research Institutes, Pfizer, PGxHealth, sanofi-aventis and Takeda; has received grant support from BioSante, Boehringer-Ingelheim, Pfizer, and Repligen Corporation; and receives royalties from Ballantine Books/Random House; Guilford Publications; the Changes in Sexual Functioning Questionnaire; and Healthcare Technology Systems, Inc.